{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:42:15Z","timestamp":1790833335501,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01-AI124316"],"award-info":[{"award-number":["U01-AI124316"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    While microbiological resistance to vancomycin in\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    is rare, clinical vancomycin treatment failures are common, and methicillin-resistant\n                    <jats:italic>S. aureus<\/jats:italic>\n                    (MRSA) strains isolated from patients after prolonged vancomycin treatment failure remain susceptible. Adaptive laboratory evolution was utilized to uncover mutational mechanisms associated with MRSA vancomycin resistance in a physiological medium as well as a bacteriological medium used in clinical susceptibility testing. Sequencing of resistant clones revealed shared and media-specific mutational outcomes, with an overlap in cell wall regulons (\n                    <jats:italic>walKRyycHI, vraSRT<\/jats:italic>\n                    ). Evolved strains displayed similar properties to resistant clinical isolates in their genetic and phenotypic traits. Importantly, resistant phenotypes that developed in physiological media did not translate into resistance in bacteriological media. Further, a bacteriological media-specific mechanism for vancomycin resistance associated with a mutated\n                    <jats:italic>mprF<\/jats:italic>\n                    was confirmed. This study bridges the gap between the understanding of clinical and microbiological vancomycin resistance in\n                    <jats:italic>S. aureus<\/jats:italic>\n                    and expands the number of allelic variants (18\u2009\u00b1\u20094 mutations for the top 5 mutated genes) that result in vancomycin resistance phenotypes.\n                  <\/jats:p>","DOI":"10.1038\/s42003-021-02339-z","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T06:03:07Z","timestamp":1624600987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Environmental conditions dictate differential evolution of vancomycin resistance in Staphylococcus aureus"],"prefix":"10.1038","volume":"4","author":[{"given":"Henrique","family":"Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8813-5679","authenticated-orcid":false,"given":"Yara","family":"Seif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor A.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hefner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitesh","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Z.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Szubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2357-6785","authenticated-orcid":false,"given":"Bernhard O.","family":"Palsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3847-0422","authenticated-orcid":false,"given":"Victor","family":"Nizet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8630-4800","authenticated-orcid":false,"given":"Adam M.","family":"Feist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"2339_CR1","unstructured":"Organization, W. H. Antimicrobial resistance: global report on surveillance. Who 8 (2014)."},{"key":"2339_CR2","doi-asserted-by":"publisher","unstructured":"Centers for Disease Control and Prevention (U.S.). Antibiotic resistance threats in the United States, 2019. https:\/\/doi.org\/10.15620\/cdc:82532 (2019).","DOI":"10.15620\/cdc:82532"},{"key":"2339_CR3","doi-asserted-by":"crossref","first-page":"D517","DOI":"10.1093\/nar\/gkz1136","volume":"48","author":"BP Alcock","year":"2020","unstructured":"Alcock, B. P. et al. CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res. 48, D517\u2013D525 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2339_CR4","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1093\/cid\/ciu542","volume":"59","author":"LA Pollack","year":"2014","unstructured":"Pollack, L. A. & Srinivasan, A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin. Infect. Dis. 59, S97\u2013S100 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"2339_CR5","doi-asserted-by":"crossref","unstructured":"Martens, E. & Demain, A. L. The antibiotic resistance crisis, with a focus on the United States. J. Antibiot. 70, 520\u2013526 (2017).","DOI":"10.1038\/ja.2017.30"},{"key":"2339_CR6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2217\/fmb-2018-0084","volume":"13","author":"K Mitsakakis","year":"2018","unstructured":"Mitsakakis, K., Kaman, W. E., Elshout, G., Specht, M. & Hays, J. P. Challenges in identifying antibiotic resistance targets for point-of-care diagnostics in general practice. Future Microbiol. 13, 1157\u20131164 (2018).","journal-title":"Future Microbiol."},{"key":"2339_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1021\/acsinfecdis.7b00194","volume":"4","author":"MA Farha","year":"2018","unstructured":"Farha, M. A., French, S., Stokes, J. M. & Brown, E. D. Bicarbonate alters bacterial susceptibility to antibiotics by targeting the proton motive force. ACS Infect. Dis. 4, 382\u2013390 (2018).","journal-title":"ACS Infect. Dis."},{"key":"2339_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2017.05.026","volume":"20","author":"SC Ersoy","year":"2017","unstructured":"Ersoy, S. C. et al. Correcting a fundamental flaw in the paradigm for antimicrobial susceptibility testing. EBioMedicine 20, 173\u2013181 (2017).","journal-title":"EBioMedicine"},{"key":"2339_CR9","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/jac\/dkv487","volume":"71","author":"M Kumaraswamy","year":"2016","unstructured":"Kumaraswamy, M. et al. Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 71, 1264\u20131269 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"2339_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-017-0819-1","volume":"16","author":"ET Mohamed","year":"2017","unstructured":"Mohamed, E. T. et al. Generation of a platform strain for ionic liquid tolerance using adaptive laboratory evolution. Microb. Cell Fact. 16, 1\u201315 (2017).","journal-title":"Microb. Cell Fact."},{"key":"2339_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2859-12-64","volume":"12","author":"M Dragosits","year":"2013","unstructured":"Dragosits, M. & Mattanovich, D. Adaptive laboratory evolution\u2014principles and applications for biotechnology. Microb. Cell Fact. 12, 1 (2013).","journal-title":"Microb. Cell Fact."},{"key":"2339_CR12","doi-asserted-by":"crossref","unstructured":"Salazar, M. J. et al. Genetic determinants enabling medium-dependent adaptation to nafcillin in methicillin-resistant Staphylococcus aureus. mSystems 5, e00828-19 (2020).","DOI":"10.1128\/mSystems.00828-19"},{"key":"2339_CR13","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1073\/pnas.0609839104","volume":"104","author":"MM Mwangi","year":"2007","unstructured":"Mwangi, M. M. et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl Acad. Sci. USA 104, 9451\u20139456 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2339_CR14","doi-asserted-by":"crossref","unstructured":"Pader, V. et al. Staphylococcus aureus inactivates daptomycin by releasing membrane phospholipids. Nat. Microbiol. 2, 16194 (2016).","DOI":"10.1038\/nmicrobiol.2016.194"},{"key":"2339_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1128\/CMR.00042-09","volume":"23","author":"BP Howden","year":"2010","unstructured":"Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P. & Grayson, M. L. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin. Microbiol. Rev. 23, 99\u2013139 (2010).","journal-title":"Clin. Microbiol. Rev."},{"key":"2339_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.7326\/0003-4819-97-3-344","volume":"97","author":"TC Sorrell","year":"1982","unstructured":"Sorrell, T. C., Packham, D. R., Shanker, S., Foldes, M. & Munro, R. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann. Intern. Med. 97, 344\u2013350 (1982).","journal-title":"Ann. Intern. Med."},{"key":"2339_CR17","first-page":"269","volume":"90","author":"WA McGuinness","year":"2017","unstructured":"McGuinness, W. A., Malachowa, N. & DeLeo, F. R. Vancomycin resistance in Staphylococcus aureus. Yale J. Biol. Med. 90, 269\u2013281 (2017).","journal-title":"Yale J. Biol. Med."},{"key":"2339_CR18","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","volume":"166","author":"LK Hidayat","year":"2006","unstructured":"Hidayat, L. K., Hsu, D. I., Quist, R., Shriner, K. A. & Wong-Beringer, A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch. Intern. Med. 166, 2138\u20132144 (2006).","journal-title":"Arch. Intern. Med."},{"key":"2339_CR19","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","volume":"350","author":"K Hiramatsu","year":"1997","unstructured":"Hiramatsu, K. et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350, 1670\u20131673 (1997).","journal-title":"Lancet"},{"key":"2339_CR20","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S0140-6736(05)78597-4","volume":"351","author":"RA Howe","year":"1998","unstructured":"Howe, R. A., Bowker, K. E., Walsh, T. R., Feest, T. G. & MacGowan, A. P. Vancomycin-resistant Staphylococcus aureus. Lancet 351, 602 (1998).","journal-title":"Lancet"},{"key":"2339_CR21","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1542\/peds.2004-2300","volume":"115","author":"BE Gonzalez","year":"2005","unstructured":"Gonzalez, B. E. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 115, 642\u2013648 (2005).","journal-title":"Pediatrics"},{"key":"2339_CR22","doi-asserted-by":"publisher","first-page":"C624","DOI":"10.1152\/ajpcell.00336.2016","volume":"312","author":"TJ McKee","year":"2017","unstructured":"McKee, T. J. & Komarova, S. V. Is it time to reinvent basic cell culture medium? Am. J. Physiol. Cell Physiol. 312, C624\u2013C626 (2017).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2339_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep17092","volume":"5","author":"K Ishii","year":"2015","unstructured":"Ishii, K. et al. Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis. Sci. Rep. 5, 17092 (2015).","journal-title":"Sci. Rep."},{"key":"2339_CR24","doi-asserted-by":"crossref","unstructured":"Gardete, S. et al. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. PLoS Pathog. 8, e1002505 (2012).","DOI":"10.1371\/journal.ppat.1002505"},{"key":"2339_CR25","doi-asserted-by":"crossref","unstructured":"Hershberg, R. Mutation\u2014the engine of evolution: studying mutation and its role in the evolution of bacteria. Cold Spring Harb. Perspect. Biol. 7, a018077 (2015).","DOI":"10.1101\/cshperspect.a018077"},{"key":"2339_CR26","doi-asserted-by":"publisher","first-page":"e1001115","DOI":"10.1371\/journal.pgen.1001115","volume":"6","author":"R Hershberg","year":"2010","unstructured":"Hershberg, R. & Petrov, D. A. Evidence that mutation is universally biased towards AT in bacteria. PLoS Genet. 6, e1001115 (2010).","journal-title":"PLoS Genet."},{"key":"2339_CR27","doi-asserted-by":"publisher","first-page":"e1001107","DOI":"10.1371\/journal.pgen.1001107","volume":"6","author":"F Hildebrand","year":"2010","unstructured":"Hildebrand, F., Meyer, A. & Eyre-Walker, A. Evidence of selection upon genomic GC-content in bacteria. PLoS Genet. 6, e1001107 (2010).","journal-title":"PLoS Genet."},{"key":"2339_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0092-8674(00)81621-9","volume":"95","author":"C Ban","year":"1998","unstructured":"Ban, C. & Yang, W. Crystal structure and ATPase activity of MutL: implications for DNA repair and mutagenesis. Cell 95, 541\u2013552 (1998).","journal-title":"Cell"},{"key":"2339_CR29","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1073\/pnas.77.2.1063","volume":"77","author":"BW Glickman","year":"1980","unstructured":"Glickman, B. W. & Radman, M. Escherichia coli mutator mutants deficient in methylation-instructed DNA mismatch correction. Proc. Natl Acad. Sci. USA 77, 1063\u20131067 (1980).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2339_CR30","doi-asserted-by":"crossref","unstructured":"Hu, Q., Peng, H. & Rao, X. Molecular events for promotion of vancomycin resistance in vancomycin intermediate Staphylococcus aureus. Front. Microbiol. 7, 1601 (2016).","DOI":"10.3389\/fmicb.2016.01601"},{"key":"2339_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/jac\/dkp394","volume":"65","author":"Y Kato","year":"2010","unstructured":"Kato, Y., Suzuki, T., Ida, T. & Maebashi, K. Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF\/VraSR. J. Antimicrob. Chemother. 65, 37\u201345 (2010).","journal-title":"J. Antimicrob. Chemother."},{"key":"2339_CR32","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/infdis\/jis252","volume":"205","author":"DR Cameron","year":"2012","unstructured":"Cameron, D. R. et al. Serine\/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus. J. Infect. Dis. 205, 1677\u20131687 (2012).","journal-title":"J. Infect. Dis."},{"key":"2339_CR33","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2014.06.046","volume":"158","author":"G Koch","year":"2014","unstructured":"Koch, G. et al. Evolution of resistance to a last-resort antibiotic in Staphylococcus aureus via bacterial competition. Cell 158, 1060\u20131071 (2014).","journal-title":"Cell"},{"key":"2339_CR34","doi-asserted-by":"publisher","first-page":"e1002359","DOI":"10.1371\/journal.ppat.1002359","volume":"7","author":"BP Howden","year":"2011","unstructured":"Howden, B. P. et al. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog. 7, e1002359 (2011).","journal-title":"PLoS Pathog."},{"key":"2339_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/infdis\/jit127","volume":"208","author":"C Vidaillac","year":"2013","unstructured":"Vidaillac, C. et al. Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 208, 67\u201374 (2013).","journal-title":"J. Infect. Dis."},{"key":"2339_CR36","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1128\/AAC.04290-14","volume":"59","author":"J Hu","year":"2015","unstructured":"Hu, J., Zhang, X., Liu, X., Chen, C. & Sun, B. Mechanism of reduced vancomycin susceptibility conferred by walK mutation in community-acquired methicillin-resistant Staphylococcus aureus strain MW2. Antimicrob. Agents Chemother. 59, 1352\u20131355 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2339_CR37","doi-asserted-by":"publisher","unstructured":"Peng, H. et al. WalK(S221P), a naturally occurring mutation, confers vancomycin resistance in VISA strain XN108. J. Antimicrobial Chemother. dkw518 https:\/\/doi.org\/10.1093\/jac\/dkw518 (2016).","DOI":"10.1093\/jac\/dkw518"},{"key":"2339_CR38","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1046\/j.1365-2958.2003.03599.x","volume":"49","author":"M Kuroda","year":"2003","unstructured":"Kuroda, M. et al. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49, 807\u2013821 (2003).","journal-title":"Mol. Microbiol."},{"key":"2339_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","volume":"1","author":"K Hiramatsu","year":"2001","unstructured":"Hiramatsu, K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis. 1, 147\u2013155 (2001).","journal-title":"Lancet Infect. Dis."},{"key":"2339_CR40","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.1128\/JB.183.16.4779-4785.2001","volume":"183","author":"QM Wang","year":"2001","unstructured":"Wang, Q. M. et al. Identification and characterization of a monofunctional glycosyltransferase from Staphylococcus aureus. J. Bacteriol. 183, 4779\u20134785 (2001).","journal-title":"J. Bacteriol."},{"key":"2339_CR41","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1128\/AAC.02333-15","volume":"60","author":"A Jousselin","year":"2015","unstructured":"Jousselin, A. et al. The Staphylococcus aureus chaperone PrsA is a new auxiliary factor of oxacillin resistance affecting penicillin-binding protein 2A. Antimicrob. Agents Chemother. 60, 1656\u20131666 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2339_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02949-y","volume":"9","author":"M Villanueva","year":"2018","unstructured":"Villanueva, M. et al. Sensory deprivation in Staphylococcus aureus. Nat. Commun. 9, 523 (2018).","journal-title":"Nat. Commun."},{"key":"2339_CR43","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1128\/JB.187.5.1815-1824.2005","volume":"187","author":"TA \u0141\u0119ski","year":"2005","unstructured":"\u0141\u0119ski, T. A. & Tomasz, A. Role of penicillin-binding Protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A. J. Bacteriol. 187, 1815\u20131824 (2005).","journal-title":"J. Bacteriol."},{"key":"2339_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1099\/mic.0.26706-0","volume":"150","author":"Y Oku","year":"2004","unstructured":"Oku, Y., Kurokawa, K., Ichihashi, N. & Sekimizu, K. Characterization of the Staphylococcus aureus mprF gene, involved in lysinylation of phosphatidylglycerol. Microbiology 150, 45\u201351 (2004).","journal-title":"Microbiology"},{"key":"2339_CR45","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3389\/fmicb.2018.01086","volume":"9","author":"F-J Chen","year":"2018","unstructured":"Chen, F.-J. et al. Effect of a point mutation in mprF on susceptibility to daptomycin, vancomycin, and oxacillin in an MRSA clinical strain. Front. Microbiol. 9, 1086 (2018).","journal-title":"Front. Microbiol."},{"key":"2339_CR46","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1128\/MMBR.62.4.1079-1093.1998","volume":"62","author":"C Goffin","year":"1998","unstructured":"Goffin, C. & Ghuysen, J. M. Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol. Mol. Biol. Rev. 62, 1079\u20131093 (1998).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"2339_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1574-6968.1994.tb06754.x","volume":"117","author":"K Murakami","year":"1994","unstructured":"Murakami, K. Nucleotide sequence of the structural gene for the penicillin-binding protein 2 of Staphylococcus aureus and the presence of a homologous gene in other staphylococci. FEMS Microbiol. Lett. 117, 131\u2013136 (1994).","journal-title":"FEMS Microbiol. Lett."},{"key":"2339_CR48","doi-asserted-by":"publisher","first-page":"7566","DOI":"10.1128\/JB.181.24.7566-7570.1999","volume":"181","author":"K Sieradzki","year":"1999","unstructured":"Sieradzki, K. & Tomasz, A. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus. J. Bacteriol. 181, 7566\u20137570 (1999).","journal-title":"J. Bacteriol."},{"key":"2339_CR49","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.meegid.2013.04.022","volume":"21","author":"G Xia","year":"2014","unstructured":"Xia, G. & Wolz, C. Phages of Staphylococcus aureus and their impact on host evolution. Infect. Genet. Evol. 21, 593\u2013601 (2014).","journal-title":"Infect. Genet. Evol."},{"key":"2339_CR50","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1128\/JB.01804-08","volume":"191","author":"C Goerke","year":"2009","unstructured":"Goerke, C. et al. Diversity of prophages in dominant Staphylococcus aureus clonal lineages. J. Bacteriol. 191, 3462\u20133468 (2009).","journal-title":"J. Bacteriol."},{"key":"2339_CR51","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1469-0691.2010.03227.x","volume":"17","author":"NJ Verkaik","year":"2011","unstructured":"Verkaik, N. J. et al. Immune evasion cluster-positive bacteriophages are highly prevalent among human Staphylococcus aureus strains, but they are not essential in the first stages of nasal colonization. Clin. Microbiol. Infect. 17, 343\u2013348 (2011).","journal-title":"Clin. Microbiol. Infect."},{"key":"2339_CR52","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1128\/JB.188.4.1310-1315.2006","volume":"188","author":"WJB van Wamel","year":"2006","unstructured":"van Wamel, W. J. B., Rooijakkers, S. H. M., Ruyken, M., van Kessel, K. P. M. & van Strijp, J. A. G. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on -hemolysin-converting bacteriophages. J. Bacteriol. 188, 1310\u20131315 (2006).","journal-title":"J. Bacteriol."},{"key":"2339_CR53","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12866-018-1336-z","volume":"18","author":"TD Read","year":"2018","unstructured":"Read, T. D. et al. USA300 Staphylococcus aureus persists on multiple body sites following an infection. BMC Microbiol. 18, 206 (2018).","journal-title":"BMC Microbiol."},{"key":"2339_CR54","doi-asserted-by":"crossref","unstructured":"Tran, P. M., Feiss, M., Kinney, K. J. & Salgado-Pab\u00f3n, W. \u03d5Sa3mw prophage as a molecular regulatory switch of Staphylococcus aureus \u03b2-toxin production. J. Bacteriol. 201, e00766-18 (2019).","DOI":"10.1128\/JB.00766-18"},{"key":"2339_CR55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1128\/AAC.01651-12","volume":"57","author":"S Boyle-Vavra","year":"2013","unstructured":"Boyle-Vavra, S., Yin, S., Jo, D. S., Montgomery, C. P. & Daum, R. S. VraT\/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus. Antimicrob. Agents Chemother. 57, 83\u201395 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2339_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep30823","volume":"6","author":"DR Cameron","year":"2016","unstructured":"Cameron, D. R., Jiang, J. H., Kostoulias, X., Foxwell, D. J. & Peleg, A. Y. Vancomycin susceptibility in methicillin-resistant Staphylococcus aureus is mediated by YycHI activation of the WalRK essential two-component regulatory system. Sci. Rep. 6, 1\u201311 (2016).","journal-title":"Sci. Rep."},{"key":"2339_CR57","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1128\/IAI.00195-12","volume":"80","author":"A Delaun\u00e9","year":"2012","unstructured":"Delaun\u00e9, A. et al. The WalKR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory response. Infect. Immun. 80, 3438\u20133453 (2012).","journal-title":"Infect. Immun."},{"key":"2339_CR58","doi-asserted-by":"publisher","first-page":"17228","DOI":"10.1073\/pnas.2008413117","volume":"117","author":"S Poudel","year":"2020","unstructured":"Poudel, S. et al. Revealing 29 sets of independently modulated genes in Staphylococcus aureus, their regulators, and role in key physiological response. Proc. Natl Acad. Sci. USA 117, 17228\u201317239 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2339_CR59","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1099\/mic.0.036129-0","volume":"156","author":"CJ Balibar","year":"2010","unstructured":"Balibar, C. J. et al. cwrA, a gene that specifically responds to cell wall damage in Staphylococcus aureus. Microbiology 156, 1372\u20131383 (2010).","journal-title":"Microbiology"},{"key":"2339_CR60","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1128\/JB.188.3.1120-1133.2006","volume":"188","author":"F McAleese","year":"2006","unstructured":"McAleese, F. et al. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate- S. aureus-type resistance to vancomycin. J. Bacteriol. 188, 1120\u20131133 (2006).","journal-title":"J. Bacteriol."},{"key":"2339_CR61","doi-asserted-by":"crossref","unstructured":"Ernst, C. M. et al. Gain-of-function mutations in the phospholipid flippase MprF confer specific daptomycin resistance. mBio 9, e01659-18 (2018).","DOI":"10.1128\/mBio.01659-18"},{"key":"2339_CR62","doi-asserted-by":"publisher","unstructured":"Ernst, C. M. & Peschel, A. MprF-mediated daptomycin resistance. Int. J. Med. Microbiol. https:\/\/doi.org\/10.1016\/j.ijmm.2019.05.010 (2019).","DOI":"10.1016\/j.ijmm.2019.05.010"},{"key":"2339_CR63","doi-asserted-by":"publisher","first-page":"e00537","DOI":"10.1128\/mBio.00537-12","volume":"4","author":"PD Fey","year":"2013","unstructured":"Fey, P. D. et al. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. MBio 4, e00537\u201312 (2013).","journal-title":"MBio"},{"key":"2339_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1057\/s41599-018-0181-x","volume":"4","author":"SH Podolsky","year":"2018","unstructured":"Podolsky, S. H. The evolving response to antibiotic resistance (1945\u20132018). Palgrave Commun. 4, 1\u20138 (2018).","journal-title":"Palgrave Commun."},{"key":"2339_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-8-39","volume":"8","author":"BP Howden","year":"2008","unstructured":"Howden, B. P. et al. Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia. BMC Microbiol. 8, 39 (2008).","journal-title":"BMC Microbiol."},{"key":"2339_CR66","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1128\/JB.188.3.1120-1133.2006","volume":"188","author":"F McAleese","year":"2006","unstructured":"McAleese, F. et al. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate-S. aureus-type resistance to vancomycin. J. Bacteriol. 188, 1120\u20131133 (2006).","journal-title":"J. Bacteriol."},{"key":"2339_CR67","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1128\/AAC.46.5.1492-1502.2002","volume":"46","author":"G Sakoulas","year":"2002","unstructured":"Sakoulas, G. et al. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob. Agents Chemother. 46, 1492\u20131502 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2339_CR68","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1128\/AAC.01213-10","volume":"55","author":"N McCallum","year":"2011","unstructured":"McCallum, N., Stutzmann Meier, P., Heusser, R. & Berger-B\u00e4chi, B. Mutational analyses of open reading frames within the vraSR operon and their roles in the cell wall stress response of Staphylococcus aureus. Antimicrob. Agents Chemother. 55, 1391\u20131402 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2339_CR69","doi-asserted-by":"publisher","first-page":"8257","DOI":"10.1128\/JB.00645-07","volume":"189","author":"S Dubrac","year":"2007","unstructured":"Dubrac, S., Boneca, I. G., Poupel, O. & Msadek, T. New insights into the WalK\/WalR (YycG\/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. J. Bacteriol. 189, 8257\u20138269 (2007).","journal-title":"J. Bacteriol."},{"key":"2339_CR70","doi-asserted-by":"publisher","first-page":"12281","DOI":"10.1073\/pnas.1005485107","volume":"107","author":"H Strahl","year":"2010","unstructured":"Strahl, H. & Hamoen, L. W. Membrane potential is important for bacterial cell division. Proc. Natl Acad. Sci. USA 107, 12281\u201312286 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2339_CR71","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1039\/C5AN02649K","volume":"141","author":"B Li","year":"2016","unstructured":"Li, B., Qiu, Y., Shi, H. & Yin, H. The importance of lag time extension in determining bacterial resistance to antibiotics. Analyst 141, 3059\u20133067 (2016).","journal-title":"Analyst"},{"key":"2339_CR72","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ebiom.2015.05.021","volume":"2","author":"L Lin","year":"2015","unstructured":"Lin, L. et al. Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant Gram-negative bacterial pathogens. EBioMedicine 2, 690\u2013698 (2015).","journal-title":"EBioMedicine"},{"key":"2339_CR73","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1086\/491709","volume":"42","author":"DP Levine","year":"2006","unstructured":"Levine, D. P. Vancomycin: a history. Clin. Infect. Dis. 42, S5\u2013S12 (2006). Suppl 1.","journal-title":"Clin. Infect. Dis."},{"key":"2339_CR74","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1586\/eri.09.123","volume":"8","author":"C Giuliano","year":"2010","unstructured":"Giuliano, C., Haase, K. K. & Hall, R. Use of vancomycin pharmacokinetic\u2013pharmacodynamic properties in the treatment of MRSA infections. Expert Rev. Anti. Infect. Ther. 8, 95\u2013106 (2010).","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"2339_CR75","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.3389\/fmicb.2018.02705","volume":"9","author":"AJ Sabat","year":"2018","unstructured":"Sabat, A. J. et al. Daptomycin resistant Staphylococcus aureus clinical strain with novel non-synonymous mutations in the mprF and vraS genes: a new insight into daptomycin resistance. Front. Microbiol. 9, 2705 (2018).","journal-title":"Front. Microbiol."},{"key":"2339_CR76","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3389\/fgene.2018.00710","volume":"9","author":"SS Costa","year":"2018","unstructured":"Costa, S. S. et al. Genetic diversity of norA, coding for a main efflux pump of Staphylococcus aureus. Front. Genet. 9, 710 (2018).","journal-title":"Front. Genet."},{"key":"2339_CR77","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1128\/AAC.01113-10","volume":"54","author":"AC Shore","year":"2010","unstructured":"Shore, A. C. et al. Identification and characterization of the multidrug resistance gene cfr in a panton-valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate. Antimicrobial Agents Chemother. 54, 4978\u20134984 (2010).","journal-title":"Antimicrobial Agents Chemother."},{"key":"2339_CR78","doi-asserted-by":"crossref","unstructured":"Machado, H. et al. A defined minimal medium for systems analyses of Staphylococcus aureus reveals strain-specific metabolic requirements. Appl. Environ. Microbiol. 85, e01773-19 (2019).","DOI":"10.1128\/AEM.01773-19"},{"key":"2339_CR79","doi-asserted-by":"publisher","first-page":"e24301","DOI":"10.1371\/journal.pone.0024301","volume":"6","author":"PR McAdam","year":"2011","unstructured":"McAdam, P. R., Holmes, A., Templeton, K. E. & Fitzgerald, J. R. Adaptive evolution of Staphylococcus aureus during chronic endobronchial infection of a cystic fibrosis patient. PLoS ONE 6, e24301 (2011).","journal-title":"PLoS ONE"},{"key":"2339_CR80","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2144\/000114559","volume":"62","author":"C Marotz","year":"2017","unstructured":"Marotz, C. et al. DNA extraction for streamlined metagenomics of diverse environmental samples. Biotechniques 62, 290\u2013293 (2017).","journal-title":"Biotechniques"},{"key":"2339_CR81","doi-asserted-by":"publisher","first-page":"e7755","DOI":"10.7717\/peerj.7755","volume":"7","author":"TC Glenn","year":"2019","unstructured":"Glenn, T. C. et al. Adapterama I: universal stubs and primers for 384 unique dual-indexed or 147,456 combinatorially-indexed Illumina libraries (iTru & iNext). PeerJ 7, e7755 (2019).","journal-title":"PeerJ"},{"key":"2339_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1469-3","volume":"18","author":"S Chen","year":"2017","unstructured":"Chen, S. et al. AfterQC: automatic filtering, trimming, error removing and quality control for fastq data. BMC Bioinforma. 18, 80 (2017).","journal-title":"BMC Bioinforma."},{"key":"2339_CR83","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4939-0554-6_12","volume":"1151","author":"DE Deatherage","year":"2014","unstructured":"Deatherage, D. E. & Barrick, J. E. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. Methods Mol. Biol. 1151, 165\u2013188 (2014).","journal-title":"Methods Mol. Biol."},{"key":"2339_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/srep08365","volume":"5","author":"T Brettin","year":"2015","unstructured":"Brettin, T. et al. RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes. Sci. Rep. 5, 8365 (2015).","journal-title":"Sci. Rep."},{"key":"2339_CR85","doi-asserted-by":"crossref","unstructured":"Phaneuf, P. V., Gosting, D., Palsson, B. O. & Feist, A. M. ALEdb 1.0: a database of mutations from adaptive laboratory evolution experimentation. Nucleic Acids Res. 47, D1164\u2013D1171 (2018).","DOI":"10.1093\/nar\/gky983"},{"key":"2339_CR86","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/molbev\/msz251","volume":"37","author":"A Anand","year":"2020","unstructured":"Anand, A. et al. OxyR is a convergent target for mutations acquired during adaptation to oxidative stress-prone metabolic states. Mol. Biol. Evol. 37, 660\u2013667 (2020).","journal-title":"Mol. Biol. Evol."},{"key":"2339_CR87","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0168-1605(94)90157-0","volume":"23","author":"J Baranyi","year":"1994","unstructured":"Baranyi, J. & Roberts, T. A. A dynamic approach to predicting bacterial growth in food. Int. J. Food Microbiol. 23, 277\u2013294 (1994).","journal-title":"Int. J. Food Microbiol."},{"key":"2339_CR88","unstructured":"Andrews, S. & Others. FastQC: a Quality Control Tool for High Throughput Sequence Data (2010)."},{"key":"2339_CR89","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"2339_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq. 2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2339_CR91","doi-asserted-by":"publisher","first-page":"8405","DOI":"10.1074\/jbc.274.13.8405","volume":"274","author":"A Peschel","year":"1999","unstructured":"Peschel, A. et al. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274, 8405\u20138410 (1999).","journal-title":"J. Biol. Chem."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02339-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02339-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02339-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T02:06:18Z","timestamp":1675476378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02339-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2339"],"URL":"https:\/\/doi.org\/10.1038\/s42003-021-02339-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.07.138933","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"assertion":[{"value":"10 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"793"}}